We are reimagining women's health

    10zyme is developing an innovative diagnostic technology driven by synthetic biology, empowering women to effectively control their cervical health.

    As an early-stage MedTech startup, we are pioneering a ‘self-test’ approach to cervical screening through our unique at-home HPV test and results kit.

    This will increase screening uptake whilst reducing strain on vital healthcare resources, providing an accessible, convenient, and life-saving cancer prevention solution to all.

    Get in Touch

    Our Research

    Patient Conversations

    Have you tested positive for HPV, been diagnosed with cervical cell changes, and/ or cervical cancer? If so, you can join our research project on the NHS Cervical Screening Programme.  Complete the form to participate.

    Diagnostic Development

    Discover how our self-test diagnostic technology screens for all 14 high-risk types of Human Papillomavirus (HPV), known to cause DNA damage, cell changes, and cancer. Our technology is novel and innovative.

    Artificial Intelligence

    Explore our data-driven diagnostic approach, where machine learning combines AI and synthetic biology in our innovative technology. This synergy enables rapid deployment of novel diagnostics. Find out more about the use of AI in our diagnostic.

    Helping the elimination of cervical cancer

    • Encouraging cervical screening participation
    • Reducing burden on healthcare
    • Reducing the incidence of cervical cancer and associated mortality

    Resources

    A wealth of information in one place

    PRIVACY POLICY

    We value your privacy at 10zyme. Please read this Privacy Policy to learn how we treat your personal data

    Follow us online